We hypothesized that the IGF2BP2 GWAS risk allele is more common among patients with HMGA2 ULs compared to other patients, but the difference was not significant (AF = 0.31 versus 0.28; OR = 1.15; P = 0.5). This evidence concerns the gene IGF2BP2 and atrial fibrillation.